← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Versatope Therapeutics, Inc.
Lowell, MA
$20,179,274
Total funding
7
Grants
Funding over time
peak $4.6M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,954,274 · 6
CDC$225,000 · 1
By mechanism
N01$17,204,617 · 2
R44$1,999,755 · 1
R43$974,902 · 4
Investigators at Versatope Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Advanced Development of Universal Vaccines for Influenza$4,002,853
N01 · FY2023 · AI
Advanced Development of Vaccines for Infectious Diseases$3,802,919
N01 · FY2020 · AI
Advanced Development of Universal Vaccines for Universal Influenza$3,608,426
N01 · FY2024 · AI
Advanced Development of Vaccines for Infectious Diseases$2,098,124
N01 · FY2019 · AI
Recombinant Outer Membrane Vesicles as a Novel Adjuvant for a Malaria Vaccine$999,993
R44 · FY2025 · AI
Recombinant Outer Membrane Vesicles as a Novel Adjuvant for a Malaria Vaccine$999,762
R44 · FY2024 · AI
Advanced Development of a Universal Influenza Vaccine$955,166
N01 · FY2025 · AI
Advanced Development of Vaccines for Infectious Diseases$892,996
N01 · FY2022 · AI
Advanced Development of Vaccines for Infectious Diseases$717,224
N01 · FY2021 · AI
Advanced Development of Vaccines for Infectious Diseases$676,909
N01 · FY2021 · AI
Novel Adjuvant for a Malaria Vaccine$450,000
N01 · FY2018 · AI
Novel C. Difficile Vaccine Using Nano-vesicle Delivery System$299,928
R43 · FY2020 · AI
Multivalent influenza vaccine using exosomes from probiotic E. coli$225,000
R43 · FY2019 · IP
Universal Influenza Vaccine$225,000
R43 · FY2018 · AI
Multivalent influenza vaccine using recombinant outer membrane vesicles$224,974
R43 · FY2019 · AI